Insiders bluebird bio, Inc.

Equities

BLUE

US09609G1004

Market Closed - Nasdaq Other stock markets 21:00:00 09/05/2024 BST			5-day change	1st Jan Change
1.12 ^USD	+14.92%		+23.99%	-18.84%

05-09	Transcript : Bluebird bio, Inc., Q1 2024 Earnings Call, May 09, 2024
05-06	Bluebird Bio, Inc. Announces Completion of First Cell Collection for LYFGENIA Gene Therapy	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bluebird Bio, Inc. Appoints Richard Paulson to the Board as Class III Director, Effective April 3, 2023	29/03/23	CI
Bluebird bio, Inc. Appoints Joseph Vittiglio, JD as Chief Business and Legal Officer	03/01/23	CI
Bluebird bio, Inc. Appoints Christopher Krawtschuk as Treasurer, Principal Financial Officer and Principal Accounting Officer	07/11/22	CI
Bluebird bio, Inc. Announces Executive Changes Effective October 14, 2022	23/09/22	CI
Bluebird Bio Chief Strategy, Financial Officer Jason Cole to Leave in October	12/09/22	MT
Bluebird bio, Inc. Announces Executive Changes	12/09/22	CI
Bluebird bio, Inc. Appoints Tom Klima as Chief Commercial & Operating Officer, Effective August 8, 2022	04/08/22	CI
Bluebird bio, Inc. Appoints Jason F. Cole as Principal Accounting Officer	02/05/22	CI
Bluebird bio, Inc. Announces Executive Changes	07/03/22	CI
Bluebird bio, Inc. appoints Charlotte Jones-Burton as Class I director, effective March 7, 2022	04/03/22	CI
Bluebird bio, Inc. Announces Resignation of Jessica Whitten as Chief Accounting Officer and Principal Accounting Officer	04/02/22	CI
Bluebird Bio, Inc. Announces Resignation of Wendy L. Dixon as Director, and Its Audit Committee and Compensation Committee	23/11/21	CI
Bluebird Bio, Inc. Announces Board and Committee Appointments	05/10/21	CI
Bluebird Bio, Inc. Announces Executive Appointments	07/09/21	CI
Bluebird Bio, Inc. Appoints Gina Consylman as Chief Financial Officer	07/09/21	CI
Bluebird Appoints Thomas J. Klima as Chief Commercial Officer, Severe Genetic Disease, Effective May 10, 2021	05/05/21	CI
Bluebird bio, Inc. Announces Employment of David Davidson, as Chief Medical Officer Ends on April 16, 2021	16/03/21	CI
Bluebird Bio, Inc. Announces Executive Changes	09/02/21	CI
Bluebird Bio, Inc. Appoints Ramy Ibrahim as Director	11/01/21	CI
Bluebird Bio, Inc. Announces Executive Changes	11/01/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders bluebird bio, Inc.

Equities

BLUE

US09609G1004

Insiders

Filters